Replacement warranty


Medtronic provides a Replacement warranty to people purchasing a new device. Our Replacement warranty allows you to use your device knowing that we’ll be here to support you should something happen.

Below you’ll find the standard Replacement warranty periods offered for Medtronic products. Replacement warranty terms can vary by model and international location. If you would like more information on your specific model, please review your product’s user guide for complete details and full warranty terms.

The length of your Replacement warranty can also vary based on your insurance provider. To check your device’s warranty status, sign in to your Medtronic account.


Insulin pump image

Insulin Pump
4 years

Sensor and transmitter image

Transmitter & Charger
1 year

Check how much longer is left on your Replacement warranty.


You can check the Replacement warranty status of your insulin pump and transmitter online by signing in to your Medtronic account.

Check Replacement warranty


You can also update your contact information online so our team can better connect with you to discuss available options and out-of-pocket cost.

Update my contact information

Female using Medtronic insulin pump

Check out what’s new with your available pump upgrade options.

MiniMed 780G system


MiniMed 780G insulin pump system


  • Automatically corrects highs if carb counts are miscalculated or bolus is occasionally missed
  • Personalize glucose target ranges with the help fo your HCP (100, 110, and 120 mg/dL)
  • Enabled for future innovations via remote software updates

Learn more   Watch Video  How it works

MiniMed 630G system with optional CGM


MiniMed 630G system with optional CGM


  • CGM optional — Guardian Sensor 3
  • Protects from low1
  • Remote bolus

Learn more   Watch Video  How it works

Want to try Guardian Connect CGM first?
Call 800-440-7867 to get started.

Give us 30 days. We'll introduce you to a smarter way to help manage diabetes.


Ready to find a way to help outsmart your diabetes? The Guardian Connect CGM evaluation program allows you to try out the Guardian Connect CGM system while using your current insulin pump at no charge for 30 days.§

If you have tried or are currently using our Enlite sensor or a Dexcom sensor, now is the best time to give the Guardian Connect CGM a try. The Guardian Connect standalone CGM is the only CGM system that provides intelligent insights that help you make more informed decisions.It is powered by our most advanced sensor to date, the Guardian 4 sensor.

Call 800-440-7867 to get started.

Frequently asked questions


If you notice a change in your device, please contact the 24-Hour Technical Support at 1-800-646-4633 option 1. Our support team will work with you to ensure your therapy stays on track.
If our support team determines you are in need of a replacement, we will send you a replacement via mail. You'll likely be expected to return your old device.
Medtronic does not sell extended warranties.
Warranty terms vary across international locations. Please contact your local Medtronic office for warranty information. Click here for Medtronic contact information in your country.
No, belt clips do not have warranty coverage. If your belt clip is no longer working, you may qualify for a replacement. Click here to learn if you are eligible.
No. Should you need to use your warranty coverage, Medtronic will provide a replacement.
No, your warranty does not reset if you receive a replacement device. Your original warranty date will transfer to the replacement device.
If your product is working as it did at the time of purchase, you can continue to use the device as prescribed by your physician. If you are experiencing a change in your device’s functionality, please contact 24-Hour Technical Support immediately at 1-800-646-4633. To learn more about your options for upgrading to newer technology during or after your warranty period, please visit our device upgrade page.
Customers with Medicare insurance will likely have a different warranty length than our standard coverage. Please sign in to your account to check your warranty status.

* Program eligibility requirements and terms and conditions apply. Subject to change.
Refers to Auto Mode. Some interaction required. Individual results may vary.
Δ Continuous Glucose Monitor
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.

WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycemia.

1 Bergenstal RM,Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N EnglJ Med. 2010;363:311–320.

§ Program Terms

  • Guardian Connect evaluation orders are billed to insurance at the time of shipping. Any patient out-of-pocket costs are held by Medtronic until the patient decides to proceed with the purchase of Guardian Connect 14 days after the shipment of their Guardian Connect system, the Therapy Consultant contacts the patient to discuss her/his decision.
  • Once all documentation is obtained and the edits are cleared for shipment according to the standard protocol for processing, the customer’s order will be released. The 30-day evaluation program will begin once the customer has completed training.
  • Starter kit includes one Guardian Connect transmitter, one charger, two universal tester, one one-press serter and one box of Guardian Sensor 3.
  • If the patient decides to proceed with the purchase of Guardian Connect, she/he keeps the Guardian Connect evaluation CGM, and Medtronic sends the patient the bill for the co-insurance amount for Guardian Connect.
  • If the patient decides not to proceed with the purchase of Guardian Connect, Medtronic will send the patient a shipping label to return the transmitter. Once the product is returned, the patient has no further obligation to Medtronic. Medtronic also will refund the payer.
  • If the patient indicates that they wish to return the CGM, but does not return the CGM within 75 days after the shipment of the Guardian Connect CGM, they will receive a bill for the cash pay cost of the transmitter as outlined in their patient agreement of $620.
  • MiniMed CGM system has certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider.
  • A valid prescription will be required to purchase. Other restrictions may apply.
  • Program terms are subject to change at any time and without notice.

Important safety information: MiniMed 780G system with SmartGuard technology with Guardian 4 sensor
The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 780G system consists of the following devices: MiniMed 780G insulin pump, the Guardian 4 transmitter, the Guardian 4 sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian 4 sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to seven days of continuous use.

The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.

WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

Important Safety Information: MiniMed 770G System With SmartGuard Technology
The MiniMed 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 770G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 770G System consists of the following devices: MiniMed 770G Insulin Pump, the Guardian Link (3) Transmitter, the Guardian Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.

The Guardian Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard Auto Mode.

WARNING: Do not use the MiniMed 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

Important Safety Information: MiniMed 630G System with SmartGuard Technology
The MiniMed 630G system with SmartGuard™ technology requires a prescription. It is intended for continuous delivery of basal insulin and administration of insulin boluses for the management of diabetes mellitus in persons 14 years of age or older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The SmartGuard feature allows one to program the pump to temporarily suspend delivery of insulin for up to two hours when the sensor glucose value falls below a predefined threshold value. The MiniMed 630G system is not intended to be used directly for making therapy adjustments or preventing or treating hypoglycemia. Therapy to prevent or treat hypoglycemia should be administered according to the recommendations of the user’s healthcare professional. The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter (BGM). A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode. Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day, or who are unwilling or unable to maintain contact with their healthcare professional, or whose vision or hearing does not allow recognition of pump signals and alarms. Insulin pumps use U100 rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately.

WARNING: The SmartGuard™ Suspend on low feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set threshold. Under some conditions of use the pump can suspend again resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the SmartGuard Suspend on low feature, it is important to read the SmartGuard Suspend on low information in the Getting Started Guide and the MiniMed 630G System User Guide and discuss proper use of the SmartGuard Suspend on low feature with your healthcare provider.

Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. Please visit www.medtronicdiabetes.com/importantsafetyinformation for more details.

The CONTOUR®NEXT LINK 2.4 Meter is used with the MiniMed 630G system.